Martin J Edelman

8PUBLICATIONS

65CO-AUTHORS

Predictive and prognostic markersMolecular targetsCommercial lawCancer cell biologyPacific Peoples theory of change models for health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 10, 2026

Pragmatic, Multicenter, Double-Blind Evaluation of Circulating Cancer-Associated Macrophage-Like Cells for Detection of Cancer in Indeterminate Pulmonary Nodules.

|Jun 03, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|May 01, 2025

Safety and Tolerability of Lete-cel in NSCLC-Reply.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Nov 22, 2024

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

|Sep 07, 2023

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Riha Vaidya, Joseph M Unger, Lu Qian

|Dec 14, 2022

Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.

Jillian A Moran, Daniel L Adams, Martin J Edelman

Pageof 2

Frequent Collaborators

4 joint publications

Joel W Neal

2 joint publications

T Jeroen N Hiltermann

Mary W Redman

David R Gandara

Gilberto Lopes

Mehmet Altan

Ticiana A Leal

Daniel L Adams

Cha-Mei Tang

Kirby P Gardner

Frequent Collaborators

4 joint publications

Joel W Neal

2 joint publications

T Jeroen N Hiltermann

2 joint publications

Mary W Redman

2 joint publications

David R Gandara